全文获取类型
收费全文 | 597篇 |
免费 | 46篇 |
国内免费 | 2篇 |
专业分类
耳鼻咽喉 | 3篇 |
儿科学 | 12篇 |
妇产科学 | 5篇 |
基础医学 | 73篇 |
口腔科学 | 11篇 |
临床医学 | 66篇 |
内科学 | 154篇 |
皮肤病学 | 7篇 |
神经病学 | 33篇 |
特种医学 | 57篇 |
外科学 | 73篇 |
综合类 | 43篇 |
预防医学 | 43篇 |
眼科学 | 9篇 |
药学 | 37篇 |
1篇 | |
肿瘤学 | 18篇 |
出版年
2021年 | 5篇 |
2020年 | 7篇 |
2019年 | 9篇 |
2018年 | 7篇 |
2017年 | 5篇 |
2016年 | 10篇 |
2015年 | 8篇 |
2014年 | 11篇 |
2013年 | 18篇 |
2012年 | 16篇 |
2011年 | 28篇 |
2010年 | 16篇 |
2009年 | 13篇 |
2008年 | 19篇 |
2007年 | 20篇 |
2006年 | 25篇 |
2005年 | 24篇 |
2004年 | 21篇 |
2003年 | 17篇 |
2002年 | 10篇 |
2001年 | 14篇 |
2000年 | 16篇 |
1999年 | 13篇 |
1998年 | 15篇 |
1997年 | 21篇 |
1996年 | 18篇 |
1995年 | 9篇 |
1994年 | 15篇 |
1993年 | 13篇 |
1992年 | 17篇 |
1991年 | 18篇 |
1990年 | 7篇 |
1989年 | 16篇 |
1988年 | 8篇 |
1987年 | 12篇 |
1986年 | 5篇 |
1985年 | 8篇 |
1983年 | 6篇 |
1982年 | 6篇 |
1981年 | 8篇 |
1978年 | 12篇 |
1977年 | 5篇 |
1976年 | 6篇 |
1973年 | 5篇 |
1972年 | 8篇 |
1971年 | 4篇 |
1969年 | 4篇 |
1968年 | 6篇 |
1966年 | 5篇 |
1927年 | 4篇 |
排序方式: 共有645条查询结果,搜索用时 0 毫秒
1.
2.
R T Means N J Olsen S B Krantz E N Dessypris S E Graber W J Stone V L O'Neil T Pincus 《Arthritis and rheumatism》1989,32(5):638-642
Two anemic patients with rheumatoid arthritis were treated with recombinant human erythropoietin (EPO) for 5 months. Both patients showed significant increases in hematocrit, red cell volumes, and marrow erythroid and megakaryocyte progenitor cells. No significant toxic effects from EPO were observed. These data indicate that EPO may be effective in overcoming the pathogenetic factors that limit erythropoiesis in rheumatoid arthritis. 相似文献
3.
4.
Polycythemia vera (PV) is a clonal disease of the hematopoietic stem cell characterized by a hyperplasia of marrow erythropoiesis, granulocytopoiesis, and megakaryocytopoiesis. We previously reported that highly purified PV blood burst-forming units-erythroid (BFU-E) are hypersensitive to recombinant human interleukin-3 (rIL-3). Because these cells may be only a subset, and not representative of marrow progenitors, we have now studied partially purified marrow hematopoietic progenitor cells. Dose-response experiments with PV marrow BFU-E showed a 38-fold increase in sensitivity to rIL-3 and a 4.3-fold increase in sensitivity to recombinant human erythropoietin (rEpo) compared with normal marrow BFU-E. In addition, PV marrow colony-forming units-granulocyte-macrophage (CFU-GM) and CFU-megakaryocyte (CFU-MK) also showed a marked hypersensitivity to rIL-3 and to human recombinant granulocyte-macrophage colony-stimulating factor (rGM-CSF). Dose-response curves with rGM-CSF and blood BFU-E showed a 48-fold increase in sensitivity. No effect of rIL-4, rIL-6, human recombinant granulocyte-CSF (rG-CSF), or macrophage-CSF (rM-CSF) was evident, nor was there any effect of PV cell-conditioned medium on normal BFU-E, when compared with normal cell-conditioned medium. Autoradiography with 125I-rEpo showed an increase in Epo receptors after maturation of PV BFU-E to CFU-E similar to that shown with normal BFU-E, but no increase of specific binding of 125I-rIL-3 by PV CD34+ cells was seen compared with normal CD34+ cells. These studies show that PV marrow hematopoietic progenitor cells are hypersensitive to rIL-3 and rGM-CSF, similar to PV blood BFU-E. While the mechanism does not appear to be due to enhanced binding of rIL-3, the hypersensitivity of PV progenitor cells to IL-3 and GM-CSF may be a key factor in the pathogenesis of PV. 相似文献
5.
6.
7.
8.
Neulen J; Raczek S; Pogorzelski M; Grunwald K; Yeo TK; Dvorak HF; Weich HA; Breckwoldt M 《Molecular human reproduction》1998,4(3):203-206
Vascularization is a prominent event during corpus luteum formation,
providing low density lipoproteins for steroid biosynthesis and enabling
transport of secreted steroids. The process of vascularization is
controlled by specific regulators. Vascular endothelial growth factor
(VEGF), otherwise named vascular permeability factor (VPF), induces
endothelial cell proliferation as well as angiogenesis in vivo and
increases capillary permeability. Here we report the expression of VEGF/VPF
mRNA by cultured human luteinized granulosa cells (GC) for at least 10
days. Without HCG VEGF/VPF expression declined after day 4 and by day 10
was reduced to approximately 30% of the value at day 4. However, after
culture in the presence of 1 U/ml human chorionic gonadotrophin (HCG),
expression of VEGF/VPF mRNA by GC was four times greater than control
experiments by day 10, and increased 100% from day 4 to day 10.
Simultaneously, HCG supplementation increased VEGF/VPF secretion by GC.
Medium VEGF/VPF on day 3 was 13 pM without and 11 pM with HCG. Medium
VEGF/VPF on day 10 was 6 pM without HCG and 29 pM with HCG. These results
suggest that vascularization of the corpus luteum is induced by
HCG-mediated effects of VEGF/VPF.
相似文献
9.
R. G. Cutlip Dr. W. T. Stauber R. H. Willison T. A. McIntosh K. H. Means 《Medical & biological engineering & computing》1997,35(5):540-543
A dynamometer is designed and fabricated to measure the force output during static and dynamic muscle actions of the plantar
flexor muscles of anaesthetised rats in vivo. The design is based on a computer-controlled DC servomotor capable of angular
velocities in excess of 17.5 rad s−1. The system controls the range of motion, angular velocity and electrical stimulation of the muscles, while monitoring the
force output at the plantar surface of the foot. The force output is measured by a piezo-electric load cell that is rated
at 5 kg capacity. Angular velocity and position are measured by a DC tachometer and potentiometer, respectively. All measurement
devices are linear (r2=0.9998). The design minimises inertial loading during high-speed angular motions, with a variation in force output of less
than 0.2%. The dynamometer proves to be an accurate and reliable system for quantifying static and dynamic forces of rat plantar
flexor muscles in vivo. 相似文献
10.
Lesions of the articular surfaces of the knee have been managed by various techniques over the last 50 years. Surgical management has involved: excising the damaged area, refashioning the underlying bone to produce a fibrous response, and introducing allograft, autograft and synthetic materials to encourage a repair matrix. The techniques and their pitfalls are reviewed and discussed, and suggestions made as to the direction of future studies for the repair of osteochondral lesions in the painful knee. 相似文献